International Consolidated Airlines Aktie
WKN DE: A1H6AJ / ISIN: ES0177542018
11.11.2022 14:58:00
|
BioNTech and Fosun Pharma Receive Emergency Use Authorization for Omicron-BA.4/BA.5 Adapted Bivalent Vaccine in Hong Kong and Special Import Authorization for Macau
Omicron BA.4/BA.5-adapted bivalent vaccine will become available in Hong Kong SAR and Macau SAR as a booster dose for individuals 12 years of age and older BA.4/BA.5-adapted bivalent vaccine combines 15-µg of mRNA encoding the wild-type spike protein found in the original COVID-19 mRNA vaccine and
Weiter zum vollständigen Artikel bei "RSS Importer"
Weiter zum vollständigen Artikel bei "RSS Importer"

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu International Consolidated Airlines S.A.mehr Nachrichten
Analysen zu International Consolidated Airlines S.A.mehr Analysen
16.09.25 | International Consolidated Airlines Outperform | Bernstein Research | |
15.09.25 | International Consolidated Airlines Outperform | Bernstein Research | |
12.09.25 | International Consolidated Airlines Equal Weight | Barclays Capital | |
09.09.25 | International Consolidated Airlines Sell | UBS AG | |
20.08.25 | International Consolidated Airlines Outperform | Bernstein Research |
Aktien in diesem Artikel
BioNTech (ADRs) | 82,15 | 0,43% |
|
International Consolidated Airlines S.A. | 4,41 | -1,12% |
|
International Consolidated Airlines Group S.A. (spons. ADRs) | 10,30 | -0,39% |
|